News Releases

Anixa Biosciences to Present at the B. Riley Oncology Investor Conference

January 13, 2021

Anixa Biosciences to Present at the H.C. Wainwright BioConnect 2021 Conference

January 5, 2021

Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine

December 21, 2020

Anixa Biosciences Covid-19 Therapy Demonstrates Comparable Potency to Remdesivir in Pre-Clinical Testing

December 14, 2020

Anixa Biosciences Announces Licensing Agreement with Cleveland Clinic for Ovarian Cancer Vaccine Technology

December 1, 2020

Anixa Biosciences and Cleveland Clinic File IND Application for Breast Cancer Vaccine

November 23, 2020

Anixa Biosciences to Host Conference Call to Provide Update on Programs

October 27, 2020

Anixa Biosciences to Present at the 2020 H.C. Wainwright 22nd Annual Global Investment Conference

September 8, 2020

Anixa and OntoChem Announce Identification of Additional Covid-19 Compounds

August 13, 2020

Anixa Biosciences Breast Cancer Vaccine Technology Nearing FDA Submission

July 28, 2020

1
2
3
4
5
6
7
8
9
10
...16
Next »

Latest News & Events

Jan 13, 2021

Anixa Biosciences to Present at the B. Riley Oncology Investor Conference

Read More...

Jan 5, 2021

Anixa Biosciences to Present at the H.C. Wainwright BioConnect 2021 Conference

Read More...

Dec 21, 2020

Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine

Read More...